Identification of neurotoxic disease

Herbert Schaumburg, James W. Albers

Research output: Contribution to journalArticle

Abstract

The majority of neurotoxic disease in North America is iatrogenic, and identification of the causative agent is rarely difficult. Industrial, environmental, and biological neurotoxic disorders may pose formidable diagnostic and therapeutic problems. This chapter emphasizes the primary role of a detailed history and suggests areas of inquiry that may help identify the cause. Information about unusual aspects of neurotoxic illness is provided, and some fundamental tenets are listed to guide the clinician who rarely encounters these disorders in everyday practice. In a final section, representative case studies from our extensive experience in clinical neurotoxicology will be presented.

Original languageEnglish (US)
Pages (from-to)11-34
Number of pages24
JournalCONTINUUM Lifelong Learning in Neurology
Volume14
Issue number5
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Neurotoxicity Syndromes
North America
History
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Identification of neurotoxic disease. / Schaumburg, Herbert; Albers, James W.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 14, No. 5, 10.2008, p. 11-34.

Research output: Contribution to journalArticle

Schaumburg, Herbert ; Albers, James W. / Identification of neurotoxic disease. In: CONTINUUM Lifelong Learning in Neurology. 2008 ; Vol. 14, No. 5. pp. 11-34.
@article{b419def05c724715a30d1bd15564b8e0,
title = "Identification of neurotoxic disease",
abstract = "The majority of neurotoxic disease in North America is iatrogenic, and identification of the causative agent is rarely difficult. Industrial, environmental, and biological neurotoxic disorders may pose formidable diagnostic and therapeutic problems. This chapter emphasizes the primary role of a detailed history and suggests areas of inquiry that may help identify the cause. Information about unusual aspects of neurotoxic illness is provided, and some fundamental tenets are listed to guide the clinician who rarely encounters these disorders in everyday practice. In a final section, representative case studies from our extensive experience in clinical neurotoxicology will be presented.",
author = "Herbert Schaumburg and Albers, {James W.}",
year = "2008",
month = "10",
doi = "10.1212/01.CON.0000337993.93291.30",
language = "English (US)",
volume = "14",
pages = "11--34",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Identification of neurotoxic disease

AU - Schaumburg, Herbert

AU - Albers, James W.

PY - 2008/10

Y1 - 2008/10

N2 - The majority of neurotoxic disease in North America is iatrogenic, and identification of the causative agent is rarely difficult. Industrial, environmental, and biological neurotoxic disorders may pose formidable diagnostic and therapeutic problems. This chapter emphasizes the primary role of a detailed history and suggests areas of inquiry that may help identify the cause. Information about unusual aspects of neurotoxic illness is provided, and some fundamental tenets are listed to guide the clinician who rarely encounters these disorders in everyday practice. In a final section, representative case studies from our extensive experience in clinical neurotoxicology will be presented.

AB - The majority of neurotoxic disease in North America is iatrogenic, and identification of the causative agent is rarely difficult. Industrial, environmental, and biological neurotoxic disorders may pose formidable diagnostic and therapeutic problems. This chapter emphasizes the primary role of a detailed history and suggests areas of inquiry that may help identify the cause. Information about unusual aspects of neurotoxic illness is provided, and some fundamental tenets are listed to guide the clinician who rarely encounters these disorders in everyday practice. In a final section, representative case studies from our extensive experience in clinical neurotoxicology will be presented.

UR - http://www.scopus.com/inward/record.url?scp=78650748695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650748695&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000337993.93291.30

DO - 10.1212/01.CON.0000337993.93291.30

M3 - Article

AN - SCOPUS:78650748695

VL - 14

SP - 11

EP - 34

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 5

ER -